543 related articles for article (PubMed ID: 12760910)
1. Imaging-guided radiofrequency ablation of solid renal tumors.
Farrell MA; Charboneau WJ; DiMarco DS; Chow GK; Zincke H; Callstrom MR; Lewis BD; Lee RA; Reading CC
AJR Am J Roentgenol; 2003 Jun; 180(6):1509-13. PubMed ID: 12760910
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous cryoablation of renal cell carcinoma guided by horizontal open magnetic resonance imaging.
Miki K; Shimomura T; Yamada H; Kishimoto K; Ohishi Y; Harada J; Egawa S
Int J Urol; 2006 Jul; 13(7):880-4. PubMed ID: 16882047
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success.
Zagoria RJ; Hawkins AD; Clark PE; Hall MC; Matlaga BR; Dyer RB; Chen MY
AJR Am J Roentgenol; 2004 Jul; 183(1):201-7. PubMed ID: 15208139
[TBL] [Abstract][Full Text] [Related]
5. Early experience with percutaneous radiofrequency ablation of small solid renal masses.
Roy-Choudhury SH; Cast JE; Cooksey G; Puri S; Breen DJ
AJR Am J Roentgenol; 2003 Apr; 180(4):1055-61. PubMed ID: 12646454
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients.
Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J
Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors.
Gervais DA; McGovern FJ; Arellano RS; McDougal WS; Mueller PR
AJR Am J Roentgenol; 2005 Jul; 185(1):64-71. PubMed ID: 15972400
[TBL] [Abstract][Full Text] [Related]
8. MRI and CT characteristics of successfully ablated renal masses: Imaging surveillance after radiofrequency ablation.
Davenport MS; Caoili EM; Cohan RH; Ellis JH; Higgins EJ; Willatt J; Fox GA
AJR Am J Roentgenol; 2009 Jun; 192(6):1571-8. PubMed ID: 19457820
[TBL] [Abstract][Full Text] [Related]
9. Radiofrequency ablation of renal tumors in the solitary kidney.
Krambeck AE; Farrell MA; Callstrom MR; Atwell TD; Charboneau JW; Chow GK; Dimarco DS; Patterson DE
Can J Urol; 2008 Aug; 15(4):4163-8; discussion 4168. PubMed ID: 18706143
[TBL] [Abstract][Full Text] [Related]
10. No evidence of disease after radiofrequency ablation in delayed nephrectomy specimens.
Park S; Strup SE; Saboorian H; Cadeddu JA
Urology; 2006 Nov; 68(5):964-7. PubMed ID: 17113888
[TBL] [Abstract][Full Text] [Related]
11. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
12. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of patients referred for percutaneous ablation of renal tumors: importance of a preprocedural diagnosis.
Tuncali K; vanSonnenberg E; Shankar S; Mortele KJ; Cibas ES; Silverman SG
AJR Am J Roentgenol; 2004 Sep; 183(3):575-82. PubMed ID: 15333338
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
Park BK; Kim CK
J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
[TBL] [Abstract][Full Text] [Related]
16. Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy.
Gebauer B; Werk M; Lopez-Hänninen E; Felix R; Althaus P
Cardiovasc Intervent Radiol; 2007; 30(4):644-9. PubMed ID: 17436034
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: initial experience.
Yamakado K; Nakatsuka A; Kobayashi S; Akeboshi M; Takaki H; Kariya Z; Kinbara H; Arima K; Yanagawa M; Hori Y; Kato H; Sugimura Y; Takeda K
Cardiovasc Intervent Radiol; 2006; 29(3):389-94. PubMed ID: 16502180
[TBL] [Abstract][Full Text] [Related]
18. Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients.
VanSonnenberg E; Shankar S; Morrison PR; Nair RT; Silverman SG; Jaklitsch MT; Liu F; Cheung L; Tuncali K; Skarin AT; Sugarbaker DJ
AJR Am J Roentgenol; 2005 Feb; 184(2):381-90. PubMed ID: 15671350
[TBL] [Abstract][Full Text] [Related]
19. MR imaging follow-up after percutaneous radiofrequency ablation of renal cell carcinoma: findings in 18 patients during first 6 months.
Merkle EM; Nour SG; Lewin JS
Radiology; 2005 Jun; 235(3):1065-71. PubMed ID: 15914485
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol.
Tan YK; Best SL; Olweny E; Park S; Trimmer C; Cadeddu JA
Urology; 2012 Apr; 79(4):827-30. PubMed ID: 22309782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
